Lumida
/BIOA
⌘K
BIOAGE Labs Inc

BIOAGE Labs Inc

BIOA
$8.49USD-1.85%-0.16 today

MARKET CAP

389.7M

P/E (TTM)

FWD P/E

DAY RANGE

$8 – $9

52W RANGE

$5
$26

AI Summary

Stalk
StalkMedium

Despite a durable long-term uptrend above the 200-day SMA, the recent Bullish Exhaustion pattern and rejection below the 9-/20-day EMAs signal waning upside momentum. With Extreme OS range status granting mean-reversion permission, the medium-term bias remains bullish, but execution should be deferred until a pullback into the rising 50-day SMA is absorbed and signs of renewed demand appear.

  • Q2 2026 loss of $0.58/sh beat $0.65 estimate; collaboration revenue flat at $2.5M YoY
  • Cash reserves of $381.3M support R&D runway through 2029
  • Q2 2026 net loss of $26.1M widened from $21.6M YoY; R&D spend at $24.4M strains cash
Full analysis →

Buying

7

institutions

Selling

5

institutions

New Positions

1

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
JH

Janus Henderson Group Plc

Q1 2026

BUY4.19 M73.19 M+3.78 M+1254.0%0.02%
BI

Blackrock, Inc.

Q2 2026

BUY2.85 M69.83 M+581.32 K+76.1%0.00%
RC

Ra Capital Management, L.P.

Q2 2026

BUY1.67 M40.97 M+21.00 K+41.9%0.36%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL702.86 K17.23 M+-624.69 K-25.8%0.02%
MM

Millennium Management LLC

Q2 2026

SELL247.62 K6.07 M+-182.84 K-19.4%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY233.98 K5.84 M+60.41 K+112.5%0.00%
RT

Renaissance Technologies LLC

Q2 2026

BUY165.70 K4.06 M+27.11 K+67.5%0.01%
CA

Citadel Advisors LLC

Q2 2026

BUY138.56 K3.40 M+121.36 K+1029.0%0.00%
AC

Aqr Capital Management LLC

Q2 2026

SELL51.19 K1.25 M+-18.15 K+3.5%0.00%
VI

Voloridge Investment Management, LLC

Q2 2026

SELL35.34 K866.18 K+-1.17 K+35.7%0.00%
MG

Man Group Plc

Q2 2026

BUYNEW18.15 K444.78 K+18.15 K+0.0%0.00%
AC

Adar1 Capital Management, LLC

Q2 2026

SELL0.000.00+-135.56 K-100.0%0.00%